Table 1 This table shows the demographics and specific ocular or systemic treatment received during the acute phase of the Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). All these were comparable between the two groups
Stevens-Johnson Syndrome and SJS/TEN overlap (n = 20) | Toxic Epidermal Necrolysis (n = 12) | p - value | |
|---|---|---|---|
Age | 44.8 ± 25.0 | 44.3 ± 26.7 | 0.960 |
Sex (Male: Female ratio) | 10: 10 | 3: 9 | 0.267 |
Intravenous Pulse Steroid | 20 (100%) | 12 (100%) | 1.000 |
Amniotic Membrane Transplant | 1 (5%) | 1 (8.33%) | 1.000 |
Intravenous immunoglobulin | 11 (55%) | 6 (50%) | 0.784 |